//
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial